Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Aurora Oncology Logo
Aurora Oncology Growth Score
34
CB Rank
182328
Heat Score
74
Aurora Oncology provides new diagnostic and treatment approaches for cancer patients.
Founded
obfuscation
PrivateGrant Aurora, Colorado, United States1-10 www.auroraoncology.com
Biotechnology
Health Care
Oncology
Overview

Aurora Oncology
Total Funding
obfuscation
Growth Score
34
Heat Score
74

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score34
-4 pts
in past quarter
Heat Score 74
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Aurora Oncology

CB Rank
182328
Aurora Oncology provides new diagnostic and treatment approaches for cancer patients.
Founded
obfuscation
PrivateGrant Aurora, Colorado, United States1-10 www.auroraoncology.com
Biotechnology
Health Care
Oncology

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name Aurora Oncology
Operating Status Active
Company Type For Profit
Founders  Michael Glode
About the Company
Aurora Oncology is an early clinical-stage biopharmaceutical company developing targeted therapeutics to image and treat non-muscle invasive bladder cancer, the most common and insidious form of bladder cancer.
Contact Email mglode@auroraoncology.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AUR-21
AUR-21 is a fusion-toxin compound targeting EGFR-overexpressing cells for the treatment of bladder cancer, utilizing a modified EGF-diphtheria toxin for specific and potent cancer cell killing.
AUR-79
AUR-79 is a theranostic agent combining diagnostic imaging and therapeutic thermal ablation for bladder cancer, using gold nanorods and anti-EGFR antibodies to target and treat cancer cells.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant
obfuscation
Grant - Aurora Oncology Logo
Grant - Aurora Oncology
1
obfuscation
— Grant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$37.1KThis year, Aurora Oncology is projected to spend $37.1K on IT, according to Aberdeen.

Active Website Tech Count

18Aurora Oncology is actively using 18 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

1Aurora Oncology has 1 registered patent in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Aurora Oncology's headquarters? Aurora Oncology is located in Aurora, Colorado, United States.Who invested in Aurora Oncology? Aurora Oncology is funded by Advanced Industries Accelerator (AIA) Program.When was the last funding round for Aurora Oncology? Aurora Oncology closed its last funding round on
obfuscation
from a Grant round.Who are Aurora Oncology's competitors? Alternatives and possible competitors to Aurora Oncology may include Eli Lilly, Pfizer, and  AstraZeneca.How much funding has Aurora Oncology raised to date? Aurora Oncology has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|